TRβ1 methylation was detected in 47% of NSCLC surgical specimens, while methylation demonstrated no significant association with any clinicopathological parameters or mutations of KRAS and EGFR [95]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.